Areteia Therapeutics Inc

Areteia Therapeutics, Inc. operates as a biotech company. The Company focuses on developing a potential first-in-class oral medication, dexpramipexole, for severe eosinophilic asthma. Areteia Therapeutics serves customers in the United States.